“These findings suggest that the central airway tree may be a useful biomarker to identify people at higher or lower COPD risk.” — Benjamin M. Smith, MD, of Columbia University Medical Center in New York City, and McGill University in Montreal on genetic variations in lung anatomy related to COPD risk.
“President Trump may be onto something here.” — William T. Abraham, MD, Director, Division of Cardiovascular Medicine, Ohio State University, on Trump’s preference for a lifestyle intervention that emphasizes diet over exercise.
“We’re operating with about half an aircraft carrier [in terms of] resources to … protect 320 million people.” — Robert Kadlec, MD, HHS assistant secretary for preparedness and response, at a hearing of the Senate Health, Education, Labor, & Pensions Committee, stressing the need for more funding to effectively prepare for public health emergencies.
“Biting my nails.” — Paul Marik, MD, chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, on the ADRENAL trial testing glucocorticoid therapy in mechanically ventilated patients in septic shock.
“The FDA’s shift in tobacco policy could make a difference in the next few years if they really do what they are planning to do.” — Maher Karam-Hage, MD, associate director of the University of Texas MD Anderson Cancer Center’s Tobacco Treatment Program, on a report that adult smoking prevalence didn’t change from 2015 to 2016.
“There’s a common sense fairness element that I don’t have to explain.” — Anders Gilberg, senior vice president of government affairs for the Medical Group Management Association (MGMA), on a glitch in Medicare’s MIPS program that keeps clinicians from determining if they are part of it.